Potent and dose-sparing next-generation SARS-CoV-2 vaccine, mRNA-1283, induces polyfunctional and durable T cell immunity.
Saved in:
| Title: | Potent and dose-sparing next-generation SARS-CoV-2 vaccine, mRNA-1283, induces polyfunctional and durable T cell immunity. |
|---|---|
| Authors: | Paila YD; Moderna, Inc., Cambridge, MA, 02142, USA., Pajon R; Moderna, Inc., Cambridge, MA, 02142, USA., Banbury B; Adaptive Biotechnologies, Seattle, WA, 98109, USA., Fields P; Adaptive Biotechnologies, Seattle, WA, 98109, USA., Maglinao M; Moderna, Inc., Cambridge, MA, 02142, USA., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, 98195, USA., Morris D; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, 98109, USA.; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA, 98195, USA., Siangphoe U; Moderna, Inc., Cambridge, MA, 02142, USA., Cohen KW; Moderna, Inc., Cambridge, MA, 02142, USA. Kristen.Cohen@modernatx.com., Paris R; Moderna, Inc., Cambridge, MA, 02142, USA. robert.paris@modernatx.com. |
| Source: | NPJ vaccines [NPJ Vaccines] 2026 Feb 19; Vol. 11 (1). Date of Electronic Publication: 2026 Feb 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
